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Editorial
J Young Pharm. 2011: What are we Aiming at?
QUALITY PUBLICATION AND ISI INDEXING
A journal is always judged based on the quality of papers, 
such as original papers, reviews, editorials, letters to the 
editor, being published and these articles play a most 
crucial role in research process. A high-quality publication 
is a means of science communication and collaboration 
of scientists in their field of expertise.[1] High-quality 
publications attract more attention of other researchers, 
stimulating new ideas and becoming highly cited. They 
boost authors’ research profile, strengthen positions 
of institutions supporting scientific productivity, and 
increase chances to get funding for future research studies. 
Currently, in most countries, academic promotion of 
an individual, recruitment, and distribution of financial 
sources for research are all subjected to the evaluation of 
a researcher/institution profile in world renowned indexing 
systems and catalogues, such as PubMed, Scopus, Index 
Copernicus, Institute for Scientific Information (ISI), etc.[2]
To achieve leading positions in academics and scientific 
field, academic and research institutions worldwide are now 
strongly encouraged to improve the quality of research 
studies and to publish papers in peer-reviewed journals 
visible in most prestigious indexing databases.[3] J Young 
Pharm. is now indexed with Caspur, Chemical Abstracts, 
DOAJ, EBSCO Publishing’s Electronic Databases, 
Expanded Academic ASAP, Genamics JournalSeek, Global 
Health, Google Scholar, Health and Wellness Research 
Center, Health Reference Center Academic, Hinari, Index 
Copernicus, OpenJGate, PrimoCentral, ProQuest, PubMed, 
Pubmed Central, SCOLOAR, SCOPUS, SIIC databases, 
Summon by Serial Solutions, and Ulrich’s International 
Periodical Directory. We are aiming at inclusion in 
Institution of Scientific Information (ISI) during this year. 
J Young Pharm. is also expecting SJR Ranking by the end 
of this year as we are already in SCOPUS. Figure 1 and   
Table 1 show the rate of acceptance/rejection rate for 
the past 2 years; we have drastically improved the refining 
of papers in the last year, as it can be seen, our rejection 
Figure 1: Acceptance and rejection rate of J Young Pharm. during the 
past 2 years (Courtesy: journalonweb)
rate is higher when compared to the year 2009. Combined 
efforts of authors, reviewers, editorial board members, and 
of course, publisher will further improve the quality of 
papers being submitted and published.
Table 1: Number of articles submitted along with 
accepted/rejected ratio during the year 2010
Total: 264 articles submitted in 2010
Article type Submitted Accepted Rejected Under 
review
Editorial 16 5 (31) 10 (63)  1 (6)
General Articles 48 8 (17) 34 (71)  6 (13)
Letter to Editor 5 2 (40) 1 (20)  2 (40)
Original Article 155 30 (19) 102 (66)  23 (15)
Pharm Analysis 6 1 (17) 5 (83) 0 (0%)
Pharm Chemistry 6 5 (83) 2 (33) −1	(−17)
Pharm Management 1 1 (100) 0 (0) 0 (0)
Pharm Marketing 1 0 (0) 1 (100) 0 (0)
Pharmaceutics 4 1 (25) 3 (75) 0 (0)
Pharmacognosy 11 2 (18) 9 (82) 0 (0)
Pharmacology 10 3 (30) 8 (80) −1	(−10)
Review Article 1 0 (0)  1 (100) 0 (0)
Total decisions 234 58 (25) 176 (75)  
Total articles 264 58 (22) 176 (67) 30 (11)
Figures in parentheses are in percentage, Courtesy: journalonweb2   Journal of Young Pharmacists Vol 3 / No 1
INCLUSION OF DOI IN THE CITED REFERENCES
Many of the articles submitted to JYP have been observed 
for the inaccurate and incomplete references, failing 
to locate the source for further information about the 
submitted manuscript. It makes our reviewers more 
concerned on correctness of these references. Uniform 
reference locators (URLs) or digital object identifiers 
(DOIs) are very useful in locating references on the Web, 
and authors are requested to provide the link/DOI in their 
reference list, which will further smoothen the peer-review 
process. Hence, JYP submission in the year 2011 will ask for 
DOI (if available) or full text link for the all the references 
cited in the submitted manuscripts.
INCLUSION OF MORE REVIEWERS
On behalf of the editorial board members, I would like 
to thank all the reviewers who have helped us in refining 
the papers submitted to J Young Pharm. We acknowledge 
them fully for their contribution and we have published a 
list of all of our reviewers in page 73. We are presenting a 
brief report on the performance of J Young Pharm during 
the year 2010 [Figure 2]. Performance of our reviewers is 
included in Table 2  and summary of JYP results for the 
year 2010 is presented in Table 3. We are constantly adding 
new reviewers; hopefully, we will have a large number 
of active and dedicated reviewers by this year end. Our 
reviewers are on time in reviewing the papers for us. Not 
all the time, our reviewers’ response toward my invitation 
is fruitful. Most of our reviewers remain busy with their 
busy research or academic schedules. We are extremely 
thankful to them for spending their precious time for 
refining articles of J Young Pharm.
Table 2: The time scale submitted to first decision for 
the year 2010
Number of articles submitted 264
Days to suggest reviewers 5.30 (0, 42)
Days taken by reviewers 14.91 (0, 47)
Days taken by Editor for decision 9.85 (0, 87)
Days until paper is under review 30.06
Days	from	first	decision	until	revision	arrives 11.55 (0, 74)
Days for Editor to take decision 3.60 (0, 11)
Articles re-reviewed 7
Days for re-review by reviewers 6.40 (0, 15)
Days to send revision decision by Editors 3.60 (0, 11)
Days from revision receipt to revision decision 13.6
Days	from	first	submission	to	acceptance 121.96 (1, 186)
Days from acceptance to publication 60.12 (12, 134)
Courtesy: journalonweb
Table 3: JYP results for the year 2010
Total number of authors registered with the site 624
Number of authors who have submitted manuscripts 216
Number of authors who have submitted more than one 
manuscripts
8
Number of manuscripts from abroad 46 (17%)
Number of original articles from abroad 27 (17%)
Courtesy: journalonweb
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Figure 2: Manuscript submissions to J Young Pharm. during the past 
2 years (Courtesy: journalonweb)
EXPANSION AND RESTRUCTURING OF 
EDITORIAL BOARD
Members of our board take a posture of being supportive 
and nurturing to authors who submit papers to the journal. 
Instead of making our mark by citing how many papers we 
reject, we want to be known for helping authors become 
better writers and researchers. To this end, our reviewers 
work with the editorial leadership team as part of an 
editorial community which unconditionally accepts all 
authors who submit their papers to the journal. In turn, 
we ask these authors to participate wholeheartedly in the 
editorial process of writing and rewriting. In this approach, 
reviewers and editors become mentors to the authors, and 
as a team, we work collaboratively to produce the best 
papers and journal possible.
An editorial board member will be expected to perform 
the following responsibilities:
•  review two to three new papers per quarter;
•  review the revised manuscripts;
•  produce supportive and useful reviews;
•  participate in internal quality improvement activities 
(e.g., answer surveys, review new forms and procedures, 
provide feedback); andJournal of Young Pharmacists Vol 3 / No 1  3
•  communicate with editors in a timely and professional 
manner.
•  Benefits of the position include the following.
•  Joining an exciting virtual community dedicated to 
improving qualitative research scholarship and scholars.
•  Collaborating with an international editorial leadership 
team.
•  Mentoring authors from around the world.
•  Learning a novel and effective approach to reviewing 
scholarly papers.
•  Receiving editorial reviewing resource materials.
•  Participating in research projects to improve the 
editorial process.
•  Learning to use new software applications for 
reviewing and editing.
•  Improving your own scholarly writing.
•  Acquiring knowledge on the latest innovations in 
qualitative inquiry.
•  Gaining a valuable credential for tenure and promotion 
review.
J Young Pharm. will be expanding its editorial board during 
the year 2011. Active reviewers will be now included as 
editorial board members. Interested authors can write to 
us along with their brief profile for possible inclusion.
FINANCIAL STRENGTHENING
J Young Pharm. is an official publication of InPharm 
Association and is being managed by self-funding. Our 
site (www.jyoungpharm.in) is fully dynamic, and the papers 
being published are now available in multiple formats 
such as PDF, Full text, ePUB, Sword repository plugin, 
eBook, etc.[4] The present global requirement of journals 
in different output formats is a costly process. We request 
all the colleges and authors to subscribe the journals and 
further strengthen us financially. There will be nominal 
pre-press charges for all the manuscripts getting published 
from the year 2011. This policy will remain throughout the 
year until next notification.
MOST CITED PAPERS
I would like to list all the most cited papers from the 
year 2009.[5-10] I encourage the authors to cite J Young 
Pharm. papers and utilize them in their research writings. 
Our citations are available in multiple formats from our 
website (http://jyoungpharm.in/currentissue.asp?sabs=n) 
and Citeulike page (http://www.citeulike.org/user/
jyoungpharm) as well.
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